Foley & Lardner LLP represented TCG Crossover on the deal.TCG Crossover acted as the lead investor in KalVista Pharmaceuticals’ $58 million registered direct offering. KalVista Pharmaceuticals,…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
